Ventripoint Medical System Plus (VMS+) 3.0

The Ventripoint Medical System Plus (VMS+) 3.0 is an advanced ultrasound image analysis system designed to provide quantitative assessment of cardiac chamber volumes and ejection fractions using a Knowledge-Based Reconstruction algorithm. It achieves this by processing 2D ultrasound images, with anatomical landmarks identified by the user and spatially correlated via a magnetic tracking system, to generate a 3D model of the heart for detailed volumetric analysis.

The Ventripoint Medical System Plus (VMS+) 3.0 is a diagnostic ultrasound image analysis system designed as an adjunct to existing ultrasound equipment. Its primary purpose is to record, analyze, store, and retrieve digital ultrasound images for computerized 3-dimensional (3D) image processing, specifically for calculating volumes and ejection fractions of the heart's four chambers: the Left Ventricle (LV), Right Ventricle (RV), Left Atrium (LA), and Right Atrium (RA). The system utilizes a Knowledge-Based Reconstruction (KBR) algorithm, which requires users to place anatomic landmarks on 2D ultrasound images. These landmarks are then used to build an accurate 3D constructed shape mesh of the heart. The VMS+ 3.0 employs a magnetic-based 3D tracking system for free-hand scanning, tracking the ultrasound transducer’s spatial coordinates during image acquisition from the secondary video output of a 2D ultrasound machine. The scientific principle behind the VMS+ 3.0 involves using the reconstructed 3D heart model to calculate chamber volumes at end-diastolic and/or end-systolic stages. Key technological features include 3D visualization capabilities, processing of data acquired by a sensor system in conjunction with ultrasound output, and operation on a Windows-based platform. The VMS+ 3.0 supports DICOM image data formats and allows for both sending images to and retrieving images from Picture Archiving and Communications Systems (PACS). Updates in this version include local KBR processing, touchscreen interface for image capture and UI, manual selection of end-diastolic and end-systolic frames, and closer placement of the magnetic transmitter to the patient. Performance data confirmed biocompatibility of patient-contacting components, electrical safety, electromagnetic compatibility, and successful software verification and validation. Nonclinical bench studies demonstrated that its volume measurement accuracy is equivalent to the previously available VMS+.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the accuracy of the Knowledge-Based Reconstruction (KBR) algorithm in VMS+ 3.0 compare to traditional 2D echocardiographic methods or cardiac MRI for assessing right ventricular volume and function, particularly in patients with complex RV morphologies?; What is the inter-observer and intra-observer variability associated with the manual placement of anatomic landmarks required by the VMS+ 3.0, and how might this impact the consistency of volume and ejection fraction calculations?; How does the closer placement of the magnetic transmitter in VMS+ 3.0 affect its susceptibility to electromagnetic interference in a typical clinical environment, and what are the practical implications for image acquisition quality?; Given the manual selection of end-diastolic and end-systolic frames, what training or guidance is provided to users to ensure standardized and accurate frame selection across different operators and patient conditions?; What are the specific advantages or limitations of the VMS+ 3.0's 3D tracking system during free-hand scanning, especially in patients with limited acoustic windows or those who are uncooperative?